Additionally, in breast cancer, RUNX2 recruits the NuRD(MTA1)/CRL4B complex to catalyze histone deacetylation and ubiquitination, affecting a cohort of key genes including PPARα and SOD2, which play pivotal roles in promoting EMT and metastasis [130]. This evidence concerns the gene MTA1 and breast carcinoma.